Home > Insider Trading > Filing (0001104659-21-076359)

Filing Details

Accession Number:: 0001104659-21-076359
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-03 16:04:20
Reporting Period:: 2021-06-01

Accepted Time:: 2021-06-03 16:04:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1285101	Colin Shannon	C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-01	14,486	$0.00	71,413	No	4	A	Direct
Common Stock	Disposition	2021-06-01	4,659	$170.45	66,754	No	4	S	Direct
Common Stock	Disposition	2021-06-01	1,811	$170.45	64,943	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-06-01	10,486	$0.00	10,486	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-06-01	4,000	$0.00	4,000	$0.00
Common Stock	Restricted Stock Unit	Acquisiton	2021-06-01	52,030	$0.00	52,030	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,974	No	4	M	Direct
4,000	No	4	M	Direct
52,030	No	4	A	Direct

Footnotes

Represents the vesting of two separate tranches of restricted stock units granted on June 1, 2020.
Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 10,486 restricted stock units from a June 1, 2020 grant of 31,460 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 4,000 restricted stock units from a June 1, 2020 grant of 8,000 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
Not applicable.
Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to 50% of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
Restricted stock units convert into the Issuer's common stock on a one-for-one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.